Chengdu Huasun Technology Group Inc Ltd
000790
Company Profile
Business description
Chengdu Huasun Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. The company does its business in industries such as Modern Chinese Medicine, Bio-pharmacy, Health Industry, and Building Steel Structure. The company's product consists of Sanqi tongsu capsule, Biyuanshu oral liquid, Huolishu oral liquid, and Smokeless moxa stick.
Contact
1168 Fuxin Avenue, High-tech Zone (West District)
No. 101, 1st Floor, Building 2
Sichuan
Chengdu611731
CHNT: +86 2866616680
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
727
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,445.10 | 33.80 | 0.36% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 65,606.71 | 76.55 | -0.12% |
| NZX 50 Index | 13,833.73 | 9.60 | 0.07% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,263.60 | 34.80 | 0.38% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |